Lubiprostone + Lubiprostone + Lubiprostone
ApprovedCompleted 1 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Constipation
Conditions
Constipation
Trial Timeline
Jan 1, 2007 → Oct 1, 2008
NCT ID
NCT00452335About Lubiprostone + Lubiprostone + Lubiprostone
Lubiprostone + Lubiprostone + Lubiprostone is a approved stage product being developed by Mallinckrodt Pharmaceuticals for Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT00452335. Target conditions include Constipation.
What happened to similar drugs?
20 of 20 similar drugs in Constipation were approved
Approved (20) Terminated (5) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00452335 | Approved | Completed |
Competing Products
20 competing products in Constipation